The multi-omics analyses of acsl1 reveal its translational significance as a tumor microenvironmental and prognostic biomarker in clear cell renal cell carcinoma.

"Declarations Competing interestsThe authors declare no competing interests. Ethical approval and participation in consentAll subjects were enrolled in accordance with the protocol authorized by the Institutional Review Board of the West China Hospital and were given informed consent. Consent for publicationAuthors who have given their contribution to the manuscript have given their consent to the submission of the manuscript. Competing interests The authors declare no competing interests."

"Funding This research was backed by funding from the China Postdoctoral Science Foundation (2021M692281), the Post-Doctor Research Project of West China Hospital, Sichuan University (21HXBH028), the 1.3.5 project for disciplines of excellence of West China Hospital, Sichuan University (No.0040205301E21), and The National Natural Science Foundation of China (Grant Nos. 81974099, 82170785) to Q.W."